SCHEMBL23768801

SCHEMBL23768801

O=C(Nc1ccc2c(c1)SCC(=O)N2Cc1ccccc1)Nc1ccc2cc[nH]c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
POLB P06746 2/20 0.45
ALDH1A1 P00352 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 2/20 0.41
MEN1 O00255 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
KMT2A Q03164 1/20 0.41
ALOX15 P16050 1/20 0.41
FAAH O00519 1/20 0.41
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
ROCK2 O75116 1/20 0.40
MAPK14 Q16539 1/20 0.40
PYGL P06737 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29978870 0.93 MAPT (0.49) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL23768795 0.93 MAPT (0.49) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL30248596 0.91 ROCK2 (0.47) MAPTPOLBALDH1A1SMN1; SMN2LMNA
SCHEMBL25028537 0.91 ROCK2 (0.47) MAPTPOLBALDH1A1SMN1; SMN2LMNA
SCHEMBL31411793 0.90 MAPT (0.51) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL23769076 0.86 MAPT (0.49) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL25028539 0.86 MAPT (0.49) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL30248606 0.86 MAPT (0.49) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL31411638 0.84 MAPT (0.58) MAPTPOLBALDH1A1CYP2C9CYP2C19
SCHEMBL23769080 0.84 STING1 (0.51) MAPTPOLBALDH1A1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151304-B Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2025-02-11 CN claimed
CN-115151304-A Small molecule interferon gene stimulating factor (STING) antagonists 库拉德夫制药私人有限公司 2022-10-04 CN claimed
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-04-20 US disclosed
WO-2021161230-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2021-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230124361-A1 SMALL MOLECULE STING ANTAGONISTS STING1, CGAS, MAVS MAPT 3716/4885POLB 2319/4885ALDH1A1 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.